Evidence map›Paper›PMID 26413133›Full record

ArticleAIDS research and therapy2015

Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012.

Lin Chen, Jiezhe Yang, Renjie Zhang, Yun Xu, Jinlei Zheng, Jianmin Jiang, Jun Jiang, Lin He, Ning Wang, Philip Chun Yeung and 1 more

Open access · goldAbstract read
In one paragraph

Article in AIDS research and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Bloodborne Infections Relevant to Dental Practice.International dental journal · 2024
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Lin ChenZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Jiezhe YangZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Renjie ZhangZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Yun XuZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Jinlei ZhengZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Jianmin JiangZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Jun JiangZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Lin HeZhejiang Provincial Center for Diseases Control and Prevention, Hangzhou, China.
Ning WangNational Center for AIDS/STD Control and Prevention, China CDC, Beijing, China.
Philip Chun YeungDepartment of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
Xiaohong PanDepartment of HIV/AIDS Prevention and Control, Zhejiang Provincial Center for Diseases Control and Prevention, 3399 Binsheng Road, Hangzhou, Zhejiang People's Republic of China.
Zhejiang Center for Disease Control and Prevention · CNChinese University of Hong Kong · CNNational Center for AIDS/STD Control and Prevention,China CDC · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objective of this study was to determine the rate of acquired immune deficiency syndrome (AIDS) in Zhejiang province and to identify specific factors associated with progression of this disease.

methodsThis study utilized a retrospective cohort to identify the specific factors involved in the progression of human immunodeficiency virus (HIV) to AIDS. We collected data of patients existing in care between 2008 and 2012 from the national surveillance system databases. We performed our analyses using a multivariate Cox proportional hazards model.

resultsThis study included 9216 HIV-positive patients (75.6 % male), which yielded 12,452 person-years (py) of follow-up-data. The AIDS progression rates were 33.9 % (2008), 33.6 % (2009), 38.1 % (2010), 30.6 % (2011) and 25.9 % (2012). We observed a significant reduction in the rate of progression Of HIV to AIDS post-2010 (Pearson χ(2) = 4341.9, P < 0.001). The cumulative AIDS progression incidence rates were 33.4, 35.4, 36.4, 37.0 and 37.04 per 100 py in 1 each of the 5 years of follow-up. This study found that age was an independent risk factor for the progression of HIV to AIDS. Compared with patients infected with HIV by homosexual transmission, patients infected with HIV by heterosexuals transmission or blood transfusion had a reduced hazard ratio (HR) for progression to AIDS (heterosexual transmission: HR = 0.695, 0.524, P = 0.007; blood transfusion: HR = 0.524, P = 0.015). Diagnosed with HIV from 2011 to 2012 and having a higher CD4+ cell count (350-500 cells/mm(3); or >500 cells/mm(3)) at baseline were independently associated with lower rates of HIV progression to AIDS [HR = 0.382, 0.380, 0.187, P < 0.001]. Patients with a CD+ T-cell count of 200-350 cells/mm(3) or greater than 350 cells/mm(3) were less likely to develop AIDS following HIV diagnosis than were those patients without HAART treatment.

conclusionThis study found a high progression rate from HIV to AIDS in HIV patients residing within Zhejiang province from 2008 to 2010. This rate decreased after 2010, which coincided with the new criteria for HAART treatment, which likely contributed to the observed reduction in the rate of progression. Initiation of HAART with higher CD4+ T-cell count may reduce rate of AIDS progression. Based on our results, we conclude that efficient strategies for HIV screening, as well as early diagnosis and treatment are necessary to reduce the progression of HIV to AIDS.

Indexed as

AIDSHAARTHIV

Identifiers

PMID26413133
PMCPMC4582728
OpenAlexW2137251694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.